Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.
Brian Kim, M.D., MTR
Advertisement
Articles by Brian Kim, M.D., MTR
Nuogen Pharma’s mission is to deliver the first FDA-approved anti-itch medication for chronic pruritus of unknown origin (CPUO) and other chronic itch conditions.
Advertisement
Latest Updated Articles
Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment TipsPublished: March 12th 2024 | Updated:
Nuogen Pharma: Innovation in the fight against itchPublished: March 30th 2020 | Updated:
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
4
Dermatology Conferences and Meetings Calendar: December 2025
5
